T cell and antibody kinetics delineate SARS-CoV-2 peptides mediating long-term immune responses in COVID-19 convalescent individuals

Journal: Science Translational Medicine

Published: 2021-04-21

DOI: 10.1126/scitranslmed.abf7517

Affiliations: 8

Authors: 16

Go to article
Institutions Share
University of Tübingen (Uni Tübingen), Germany 0.43
DKTK Partner Site Tuebingen, Germany 0.36
University Hospital Tübingen (UKT), Uni Tübingen, Germany 0.15
German Cancer Research Center in the Helmholtz Association (DKFZ), Germany 0.05
Robert Bosch Stiftung GmbH, Germany 0.02